Press release
Global Genetic Testing Market to witness CAGR of 12.94% during 2018 to 2023
The recent study on the Global Genetic Testing market covers in-depth analysis of the market on the basis of type, disease, technology, and geography. The report also covers the country level analysis within the regions as well. Additionally, the report covers the key trends in the market along with drivers and restraint during the forecast period 2018-2023, with 2017 as the base year. According to the report titled “Global Genetic Testing Market”, the market is expected to increase from US$5.060 billion in 2018 to US$9.296 billion by 2023, at a CAGR of 12.94% during the projected period. The report has segmented the global genetic testing market by type (prenatal testing, newborn screening, diagnostic testing, carrier testing, and predictive & pre-symptomatic testing), by disease (cancer, cystic fibrosis, sickle cell anemia, Duchenne muscular dystrophy, Alzheimer disease, thalassemia, Huntington disease, and others), by technology (cytogenetic testing, biochemical testing, and molecular testing) and by geography (North America, South America, Europe, Middle East and Africa, and Asia Pacific). Genetic testing involves carrying out the range of tests on the sample of DNA derived from blood, saliva, skin, and other tissues. Genetic tests are majorly conducted for diagnosing genetic disorders, identifying the mutation in the gene, and designing the treatment package. The growing prevalence of genetic disorders has been instrumental in driving the market. Moreover, the gradual decrease in the cost of the genetic test has increased the number of genetic tests being conducted globally. However, concerns regarding the confidentiality and misleading advice along with the difficulty in interpreting the result have limited the market growth.Following driver, restraints, and opportunities have been covered in this report-
Drivers
-Growing prevalence of genetic diseases
-Falling prices of genetic testing
Restraints
-Lack of constructive perception
-Difficult interpretation of genetic test results
Opportunities
-Workplace wellness program
-Increasing the application of genetic tests
-Prenatal testing is anticipated to witness rapid growth during the forecast period
Prenatal testing is often conducted during the pregnancy to detect the possibility of the baby having a genetic or chromosome disorder. The continuous technological advancement has made prenatal testing relatively affordable and gives more accurate results. Recently, the cell-free DNA screening was introduced which screens the mother’s blood that contains DNA from the baby to look for genetic disorders in the fetus. Moreover, the prevalence of birth defects is increasing globally which is correlated with the increasing trend of obesity among women that is expected to drive the genetic testing market for prenatal testing during the forecast period.
The prevalence of cancer is driving the genetic testing market
Cancer is one of the leading causes of mortality and morbidity globally and was responsible for 8.8 million deaths in 2015. Moreover, 5%-10% of all the cancers are caused by inherited genetic mutation. The growing prevalence of cancers is leading to significant increase in the number of the genetic test conducted for testing cancer.
Continuous reduction in the genome sequencing cost is increasing the adoption of molecular testing technology
Molecular testing involves studying a single gene or short lengths of DNA to identify variations or mutation that causes a genetic disorder. This type of test is applicable when the gene sequence of interest is known. In fact, it is the most effective method for small DNA mutation, more specifically when the biochemical test cannot be developed and the function of the protein is unknown. The molecular testing is used for prenatal and predictive genetic testing, risk assessment for family cancer and the diagnosis of many neurological disorders. Moreover, the continuous technological advancement and increasing number of start-ups is reducing the cost of genome sequencing which has rendered the cost of test relatively affordable.
North America holds a significant share in the market
Genetic testing is a significant element within the healthcare industry in the United States. The gradual increase in the healthcare expenditure is an indicator of an increase in the spending on genetic testing. In fact, the number of diseases for which genetic testing is available has increased gradually over the years. Similarly, in Canada, the rapid technological innovation and growth in the discovery of genes associated with the hereditary disease have led to the increasing number of genetic test available in Canada as well. Moreover, the recent regulatory support for the direct-to-consumer genetic testing and the increase in the coverage of health insurance covering the genetic test has been instrumental in driving the genetic testing market in North America.
Some of the major players discussed in the reports are Abbot, Ariosa Diagnostic Inc., Biocartis, and Luminex Corporation among others.
For sample request or purchase options, please click the link below:
https://www.knowledge-sourcing.com/products/global-genetic-testing-market-forecasts-from-2018-to-2023
Knowledge Sourcing Intelligence is a market research and consulting firm based out of India. Driven by industry experts, the company provides syndicated reports, custom research, and consulting services. Our proprietary data analytics model blended with quality primary and secondary research data assists in generating quality reports providing crucial insights to managers and decision makers. The services offered by us help companies to gain required a competitive edge. Our expertise across ten industries such as ICT, Chemicals, Semiconductors, Healthcare among others caters to diverse client needs.
Knowledge Sourcing Intelligence
2nd Floor, D-77, Sector 63
Noida, India
Call: +1-866-714-4587
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Genetic Testing Market to witness CAGR of 12.94% during 2018 to 2023 here
News-ID: 976413 • Views: …
More Releases from Knowledge Sourcing Intelligence LLP
Microcarrier Market is projected to surpass US$1,989.084 million by 2029 at a CA …
According to a new study published by Knowledge Sourcing Intelligence, the microcarrier market is projected to grow at a CAGR of 11.55% between 2022 and 2029 to reach US$1,989.084 million by 2029.
An aid matrix called a microcarrier allows more adherent cells to enter bioreactors. In the large-scale commercial production of biologics and vaccines, microcarriers cultivate adherent cellular populations that produce viruses or proteins. The scope of this document states…
Feed Grade Threonine Market Size, Trends, In-depth Analysis, Research Report For …
Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of "feed-grade threonine market - which is forecasted from 2023 to 2028".
The feed-grade threonine market is estimated to grow at a CAGR of 5.12% during the forecast period.
With both quantitative and qualitative analysis, this study intends to offer an in-depth assessment of the feed-grade threonine market. This will further help to establish business and growth plans…
Global Horse Feed Market Size, Trends, In-depth Analysis, Research Report Foreca …
Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of "global horse feed market - which is forecasted from 2023 to 2028".
The global horse feed market is estimated to grow at a CAGR of 4.93% during the forecast period.
With both quantitative and qualitative analysis, this study intends to offer an in-depth assessment of the global horse feed market. This will further help to establish business…
Wheat Seed Treatment Market Size, Trends, In-depth Analysis, Research Report For …
Knowledge Sourcing Intelligence announces the publication of a new analysis report on the market of "wheat seed treatment market - which is forecasted from 2023 to 2028".
The Wheat seed Treatment market is estimated to grow at a CAGR of 7.49% during the forecast period.
With both quantitative and qualitative analysis, this study intends to offer an in-depth assessment of the wheat seed treatment market. This will further help to establish business…
More Releases for Genetic
Genetic Testing Market to Register Growth due to Increasing Prevalence of Geneti …
The prevalence of diseases, including chronic and genetic diseases, is rising at a swift pace. According to the World Health Organization, a genetic disorder named sickle cell anemia is primarily common among people who had ancestors in India, South America, Central America, Sub-Saharan Africa, Mediterranean countries (including Greece, Turkey, and Italy), Cuba, and Saudi Arabia. In addition to this, the high prevalence of chronic diseases, such as cancer, is also…
Genetic Testing Market Demand 2018; by Method Molecular Genetic Test/ DNA Test, …
Universal Genetic Testing Market 2018 Research Report implements an exhaustive study on Market Research Future. This Report Cover Key Market Driver, market size, growth rate, opportunities, market Dynamics and Overall Analysis. And also cover the other information such as Genetic Testing market trends, Prominent players, chapter-wise Description followed by various user perceptions and Forecast till 2023.
Genetic Testing Market - Global Insights
The Global Genetic Testing Market is growing with the rapid…
Global Preimplantation Genetic Testing Market: Growing Public-Private Investment …
The report "Preimplantation Genetic Testing Market by Products & Services (Reagents and Consumables, Software and Services and Instruments), Technology (Single-Nucleotide Polymorphism, Next-Generation Sequencing, Fluorescence in Situ Hybridization, Comparative Genomic Hybridization and Polymerase Chain Reaction), Procedure Type (Preimplantation Genetic Screening, and Preimplantation Genetic Diagnosis), Application (Single Gene Disorders, HLA Typing, Structural Chromosomal Abnormalities, X-Linked Disorders, Aneuploidy and Gender Identification), End User (Hospitals, Diagnostic Labs, and Service Providers, Research Laboratories & Academic…
Reproductive Genetic Innovations to Discuss Novelties in Preimplantation Genetic …
Reproductive Genetic Innovations (RGI) will be attending and presenting at the 54th Mexican Congress of Reproductive Medicine hosted by the Associacion Mexicana de Medicina de la Reproduccion, A.C. (AMMR). This is the first year RGI has attended and presented at this conference. Booth G-H (July 17th to the 20th)
President and Lab Director, Dr. Svetlana Rechitsky, will be giving a lecture on Wednesday afternoon (July 19th) titled, "Novelties in…
Breast Cancer Predictive Genetic Testing Market Breast Cancer Predictive Genetic …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
Cancer Susceptibility Testing
1.1 Prologue to Cancer Susceptibility
1.2 Aspects of Cancer Susceptibility Testing
Breast Cancer Susceptibility
2.1 Conceptual of Breast Cancer Susceptibility
2.2 Trail of the Inherited Susceptible Genes
Hereditary Breast Cancer Genes
3.1 High Penetrant Genes
3.1.1 Breast Cancer Gene1 (BRCA1)
3.1.2 Breast Cancer Gene 2 (BRCA2)
…
Rising Prevalence of Genetic Disorders Propels Prenatal and New-born Genetic Tes …
Global Prenatal and New-born Genetic Testing Market: Snapshot
Prenatal and new-born genetic tests refer to the systematic diagnostic tests and screenings undertaken to determine the risk of certain genetic disorders in newborn children and fetuses in stages as early as eight to ten weeks of gestation. The use of a variety of screening and diagnostic tools for detecting chromosomal abnormalities and the risk of diseases such as Patau syndrome, Down…